why bother again

I reckon you pumpers have to at some stage admit defeat.

This stock is going nowhere even with your best efforts.

If it won't pay a dividend while Relenza is in patent, I can hardly see it pay a dividend while it isn't in a couple of years.

Its still losing monbey and will use up its kitty before then.

With the recession, governements are cutting back on health expenditure.

The pipeline is worthless otherwise we would have had a bid by some reputable pharma with its stockprice so low.

Suggest you guys sell and buy CSL.